158 related articles for article (PubMed ID: 26754327)
1. Mesenchymal Stem Cells Ageing: Targeting the "Purinome" to Promote Osteogenic Differentiation and Bone Repair.
Noronha-Matos JB; Correia-de-Sá P
J Cell Physiol; 2016 Sep; 231(9):1852-61. PubMed ID: 26754327
[TBL] [Abstract][Full Text] [Related]
2. Adult mesenchymal stem cells: is there a role for purine receptors in their osteogenic differentiation?
Carluccio M; Ziberi S; Zuccarini M; Giuliani P; Caciagli F; Di Iorio P; Ciccarelli R
Purinergic Signal; 2020 Sep; 16(3):263-287. PubMed ID: 32500422
[TBL] [Abstract][Full Text] [Related]
3. Extracellular Nucleotide Hydrolysis in Dermal and Limbal Mesenchymal Stem Cells: A Source of Adenosine Production.
Naasani LIS; Rodrigues C; de Campos RP; Beckenkamp LR; Iser IC; Bertoni APS; Wink MR
J Cell Biochem; 2017 Aug; 118(8):2430-2442. PubMed ID: 28120532
[TBL] [Abstract][Full Text] [Related]
4. Silencing NTPDase3 activity rehabilitates the osteogenic commitment of post-menopausal stem cell bone progenitors.
Noronha-Matos JB; Pinto-Cardoso R; Bessa-Andrês C; Magalhães-Cardoso MT; Ferreirinha F; Costa MA; Marinhas J; Freitas R; Lemos R; Vilaça A; Oliveira A; Pelletier J; Sévigny J; Correia-de-Sá P
Stem Cell Res Ther; 2023 Apr; 14(1):97. PubMed ID: 37076930
[TBL] [Abstract][Full Text] [Related]
5. Expression of P2 Purinergic Receptors in Mesenchymal Stem Cells and Their Roles in Extracellular Nucleotide Regulation of Cell Functions.
Jiang LH; Hao Y; Mousawi F; Peng H; Yang X
J Cell Physiol; 2017 Feb; 232(2):287-297. PubMed ID: 27403750
[TBL] [Abstract][Full Text] [Related]
6. Extracellular nucleotides and nucleosides as signalling molecules.
Giuliani AL; Sarti AC; Di Virgilio F
Immunol Lett; 2019 Jan; 205():16-24. PubMed ID: 30439478
[TBL] [Abstract][Full Text] [Related]
7. Role of ecto-NTPDases on UDP-sensitive P2Y(6) receptor activation during osteogenic differentiation of primary bone marrow stromal cells from postmenopausal women.
Noronha-Matos JB; Costa MA; Magalhães-Cardoso MT; Ferreirinha F; Pelletier J; Freitas R; Neves JM; Sévigny J; Correia-de-Sá P
J Cell Physiol; 2012 Jun; 227(6):2694-709. PubMed ID: 21898410
[TBL] [Abstract][Full Text] [Related]
8. Chondrogenic Differentiation of Human Mesenchymal Stem Cells Results in Substantial Changes of Ecto-Nucleotides Metabolism.
Roszek K; Porowińska D; Bajek A; Hołysz M; Czarnecka J
J Cell Biochem; 2015 Dec; 116(12):2915-23. PubMed ID: 26018728
[TBL] [Abstract][Full Text] [Related]
9. Could hypoxia rehabilitate the osteochondral diseased interface? Lessons from the interplay of hypoxia and purinergic signals elsewhere.
Pinto-Cardoso R; Bessa-Andrês C; Correia-de-Sá P; Bernardo Noronha-Matos J
Biochem Pharmacol; 2023 Aug; 214():115646. PubMed ID: 37321413
[TBL] [Abstract][Full Text] [Related]
10. Bortezomib enhances the osteogenic differentiation capacity of human mesenchymal stromal cells derived from bone marrow and placental tissues.
Sanvoranart T; Supokawej A; Kheolamai P; U-Pratya Y; Klincumhom N; Manochantr S; Wattanapanitch M; Issaragrisil S
Biochem Biophys Res Commun; 2014 May; 447(4):580-5. PubMed ID: 24747566
[TBL] [Abstract][Full Text] [Related]
11. Purinergic Signaling Regulates the Transforming Growth Factor-β3-Induced Chondrogenic Response of Mesenchymal Stem Cells to Hydrostatic Pressure.
Steward AJ; Kelly DJ; Wagner DR
Tissue Eng Part A; 2016 Jun; 22(11-12):831-9. PubMed ID: 27137792
[TBL] [Abstract][Full Text] [Related]
12. Neurogenic Differentiation of Mesenchymal Stem Cells Induces Alterations in Extracellular Nucleotides Metabolism.
Czarnecka J; Porowińska D; Bajek A; Hołysz M; Roszek K
J Cell Biochem; 2017 Mar; 118(3):478-486. PubMed ID: 27472650
[TBL] [Abstract][Full Text] [Related]
13. Mesenchymal Stem Cell Spheroids Retain Osteogenic Phenotype Through α2β1 Signaling.
Murphy KC; Hoch AI; Harvestine JN; Zhou D; Leach JK
Stem Cells Transl Med; 2016 Sep; 5(9):1229-37. PubMed ID: 27365484
[TBL] [Abstract][Full Text] [Related]
14. The Effects of TNF-α on Osteogenic Differentiation of Umbilical Cord Derived Mesenchymal Stem Cells.
Marupanthorn K; Tantrawatpan C; Tantikanlayaporn D; Kheolamai P; Manochantr S
J Med Assoc Thai; 2015 Apr; 98 Suppl 3():S34-40. PubMed ID: 26387386
[TBL] [Abstract][Full Text] [Related]
15. How to influence the mesenchymal stem cells fate? Emerging role of ectoenzymes metabolizing nucleotides.
Roszek K; Wujak M
J Cell Physiol; 2018 Jan; 234(1):320-334. PubMed ID: 30078187
[TBL] [Abstract][Full Text] [Related]
16. Purinergic receptors influence the differentiation of human mesenchymal stem cells.
Zippel N; Limbach CA; Ratajski N; Urban C; Luparello C; Pansky A; Kassack MU; Tobiasch E
Stem Cells Dev; 2012 Apr; 21(6):884-900. PubMed ID: 21740266
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of SLC41A1 magnesium transporter promotes mineralization and attenuates magnesium inhibition during osteogenesis of mesenchymal stromal cells.
Tsao YT; Shih YY; Liu YA; Liu YS; Lee OK
Stem Cell Res Ther; 2017 Feb; 8(1):39. PubMed ID: 28222767
[TBL] [Abstract][Full Text] [Related]
18. Interleukin-1β induces differentiation of human mesenchymal stem cells into osteoblasts via the Wnt-5a/receptor tyrosine kinase-like orphan receptor 2 pathway.
Sonomoto K; Yamaoka K; Oshita K; Fukuyo S; Zhang X; Nakano K; Okada Y; Tanaka Y
Arthritis Rheum; 2012 Oct; 64(10):3355-63. PubMed ID: 22674197
[TBL] [Abstract][Full Text] [Related]
19. Age-related CXC chemokine receptor-4-deficiency impairs osteogenic differentiation potency of mouse bone marrow mesenchymal stromal stem cells.
Guang LG; Boskey AL; Zhu W
Int J Biochem Cell Biol; 2013 Aug; 45(8):1813-20. PubMed ID: 23742988
[TBL] [Abstract][Full Text] [Related]
20. RIA fractions contain mesenchymal stroma cells with high osteogenic potency.
Kuehlfluck P; Moghaddam A; Helbig L; Child C; Wildemann B; Schmidmaier G;
Injury; 2015 Dec; 46 Suppl 8():S23-32. PubMed ID: 26747914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
